Cornerstone Advisors (Washington)’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-974
| Closed | -$80K | – | 867 |
|
|
2019
Q2 | $80K | Buy |
974
+207
| +27% | +$16.2K | 0.01% | 291 |
|
|
2019
Q1 | $62K | Buy |
767
+291
| +61% | +$22.9K | 0.01% | 307 |
|
|
2018
Q4 | $36K | Buy |
476
+105
| +28% | +$8.2K | 0.01% | 368 |
|
|
2018
Q3 | $29K | Buy |
371
+80
| +27% | +$6.05K | 0.02% | 451 |
|
|
2018
Q2 | $20K | Buy |
291
+122
| +72% | +$8.78K | 0.01% | 500 |
|
|
2018
Q1 | $12K | Buy |
169
+80
| +90% | +$5.54K | 0.01% | 561 |
|
|
2017
Q4 | $6K | Hold |
89
| – | – | ﹤0.01% | 658 |
|
|
2017
Q3 | $6K | Sell |
89
-94
| -51% | -$5.94K | ﹤0.01% | 656 |
|
|
2017
Q2 | $12K | Buy |
183
+94
| +106% | +$6.14K | 0.01% | 555 |
|
|
2017
Q1 | $6K | Hold |
89
| – | – | ﹤0.01% | 660 |
|
|
2016
Q4 | $5K | Sell |
89
-420
| -83% | -$23.8K | ﹤0.01% | 697 |
|
|
2016
Q3 | $33K | Hold |
509
| – | – | 0.03% | 330 |
|
|
2016
Q2 | $31K | Buy |
509
+62
| +14% | +$3.6K | 0.03% | 211 |
|
|
2016
Q1 | $25K | Sell |
447
-70
| -14% | -$4.21K | 0.03% | 248 |
|
|
2015
Q4 | $35K | Sell |
517
-202
| -28% | -$13.2K | 0.04% | 230 |
|
|
2015
Q3 | $46K | Buy |
719
+46
| +7% | +$3.03K | 0.04% | 187 |
|
|
2015
Q2 | $43K | Buy |
673
+24
| +4% | +$1.64K | 0.04% | 179 |
|
|
2015
Q1 | $44K | Buy |
649
+145
| +29% | +$10.1K | 0.03% | 199 |
|
|
2014
Q4 | $35K | Buy |
504
+57
| +13% | +$4.08K | 0.03% | 214 |
|
|
2014
Q3 | $32K | Hold |
447
| – | – | 0.03% | 99 |
|
|
2014
Q2 | $33K | Sell |
447
-12
| -3% | -$867 | 0.03% | 108 |
|
|
2014
Q1 | $30K | Buy |
459
+18
| +4% | +$1.16K | 0.04% | 106 |
|
|
2013
Q4 | $26K | Hold |
441
| – | – | 0.04% | 92 |
|
|
2013
Q3 | $23K | Hold |
441
| – | – | 0.04% | 95 |
|
|
2013
Q2 | $21K | Buy |
+441
| New | +$22.5K | 0.05% | 52 |
|
Other funds holding AZN
